Search Results 91-100 of 17257 for protein intake optimization
About this study. This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, ...
... protein-based therapeutics in the areas of immunology, hematology, and ... enhance the target selection, target optimization ... requirements; actions of ...
... optimal dosages and risks/benefits. In the later ... Serum M-protein ≥ 1 g/dL (≥ 10 g/L). Urine M ... Is willing and able to adhere to the study visit schedule ...
... optimal dosages and risks/benefits. In the later ... Serum monoclonal protein >= 1.0 g/dL; > 200 mg of ... requirements of the trial; Is pregnant or ...
Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic SPORE, “Optimal ...
... optimal dosages and risks/benefits. In the later ... Serum monoclonal protein ≥ 0.5g by protein electrophoresis; ... requirements of the POMALYST REMS® program.
... optimal dosages and risks/benefits. In the later ... Subject must be able and willing to give written informed consent and to comply with the requirements of this ...
To address these knowledge gaps, an individualized, biomarker-guided corticosteroid dosing approach using C-reactive protein (CRP) was recently evaluated in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.